Journal of Preventive Medicine and Public Health

Special Article

Measuring Trends in the Socioeconomic Burden of Disease in Korea, 2007-2015: Tae Eung Kim, Ru-Gyeom Lee, So-Youn Park, In-Hwan Oh; J Prev Med Public Health. 2022;55(1):19-27. Published online January 31, 2022; DOI: https://doi.org/10.3961/jpmph.21.594

3,911 View
145 Download
5 Web of Science
5 Crossref

Abstract Summary PDF Supplementary Material

This study estimated the direct and indirect socioeconomic costs of 238 diseases and 22 injuries from a social perspective in Korea from 2007 to 2015. The socioeconomic cost of each disease group was calculated based on the Korean Standard Disease Classification System. Direct costs were estimated using health insurance claims data provided by the National Health Insurance Service. The numbers of outpatients and inpatients with the main diagnostic codes for each disease were selected as a proxy indicator for estimating patients’ medical use behavior by disease. The economic burden of disease from 2007 to 2015 showed an approximately 20% increase in total costs. From 2007 to 2015, communicable diseases (including infectious, maternal, pediatric, and nutritional diseases) accounted for 8.9-12.2% of the socioeconomic burden, while non-infectious diseases accounted for 65.7-70.7% and injuries accounted for 19.1-22.8%. The top 5 diseases in terms of the socioeconomic burden were self-harm (which took the top spot for 8 years), followed by cirrhosis of the liver, liver cancer, ischemic heart disease, and upper respiratory infections in 2007. Since 2010, the economic burden of conditions such as low back pain, falls, and acute bronchitis has been included in this ranking. This study expanded the scope of calculating the burden of disease at the national level by calculating the burden of disease in Koreans by gender and disease. These findings can be used as indicators of health equality and as useful data for establishing community-centered (or customized) health promotion policies, projects, and national health policy goals.

Summary

Korean summary
2007년에서 2015년 기간의 건강보험 자료 등을 이용하여, 해당기간의 경제적 질병부담을 측정하였으며, 해당 기간동안 경제적 질병부담은 20%의 증가를 나타내었다. 동 기간동안 비감염성 질환의 경제적 질병부담의 비율은 약 70%로 나타났으며, 감염성 질환은 약 10%, 손상은 20%로 나타났다. 한편 개별 질병군 기준으로는 자살을 포함한 자해가 1위를 차지한 해가 가장 많았다.

Citations

Citations to this article as recorded by

Time Trend Analysis of Comorbidities in Ankylosing Spondylitis: A Population-Based Study from 53,142 Hospitalizations in Poland
Katarzyna Helon, Małgorzata Wisłowska, Krzysztof Kanecki, Paweł Goryński, Aneta Nitsch-Osuch, Krzysztof Bonek
Journal of Clinical Medicine.2024; 13(2): 602. CrossRef
Assessment and nonsurgical management of low back pain: a narrative review
Sung Cheol Park, Min-Seok Kang, Jae Hyuk Yang, Tae-Hoon Kim
The Korean Journal of Internal Medicine.2023; 38(1): 16. CrossRef
Therapeutic Duplication as a Medication Error Risk in Fixed-Dose Combination Drugs for Dyslipidemia: A Nationwide Study
Wonbin Choi, Hyunji Koo, Kyeong Hye Jeong, Eunyoung Kim, Seung-Hun You, Min-Taek Lee, Sun-Young Jung
Korean Journal of Clinical Pharmacy.2023; 33(3): 168. CrossRef
Effects of a Senior Musical Program on the Physical Function and Cognitive Abilities of Older Women in the Community
Byeong-Soo Kim, Ji-Youn Kim, Sam-Ho Park, Myung-Mo Lee
Healthcare.2023; 11(8): 1174. CrossRef
Estimated trends in hospitalizations due to occupational injuries in Korea based on the Korean National Hospital Discharge In-depth Injury Survey (2006-2019)
Seong-Uk Baek, Won-Tae Lee, Min-Seok Kim, Myeong-Hun Lim, Jin-Ha Yoon
Epidemiology and Health.2023; 45: e2023042. CrossRef

Original Article

Estimating Influenza-associated Mortality in Korea: The 2009-2016 Seasons: Kwan Hong, Sangho Sohn, Byung Chul Chun; J Prev Med Public Health. 2019;52(5):308-315. Published online August 23, 2019; DOI: https://doi.org/10.3961/jpmph.19.156

21,104 View
320 Download
14 Crossref

Abstract Summary PDF

Objectives
Estimating influenza-associated mortality is important since seasonal influenza affects persons of all ages, causing severe illness or death. This study aimed to estimate influenza-associated mortality, considering both periodic changes and age-specific mortality by influenza subtypes.
Methods
Using the Microdata Integrated Service from Statistics Korea, we collected weekly mortality data including cause of death. Laboratory surveillance data of respiratory viruses from 2009 to 2016 were obtained from the Korea Centers for Disease Control and Prevention. After adjusting for the annual age-specific population size, we used a negative binomial regression model by age group and influenza subtype.
Results
Overall, 1 859 890 deaths were observed and the average rate of influenza virus positivity was 14.7% (standard deviation [SD], 5.8), with the following subtype distribution: A(H1N1), 5.0% (SD, 5.8); A(H3N2), 4.4% (SD, 3.4); and B, 5.3% (SD, 3.7). As a result, among individuals under 65 years old, 6774 (0.51%) all-cause deaths, 2521 (3.05%) respiratory or circulatory deaths, and 1048 (18.23%) influenza or pneumonia deaths were estimated. Among those 65 years of age or older, 30 414 (2.27%) all-cause deaths, 16 411 (3.42%) respiratory or circulatory deaths, and 4906 (6.87%) influenza or pneumonia deaths were estimated. Influenza A(H3N2) virus was the major contributor to influenza-associated all-cause and respiratory or circulatory deaths in both age groups. However, influenza A(H1N1) virus–associated influenza or pneumonia deaths were more common in those under 65 years old.
Conclusions
Influenza-associated mortality was substantial during this period, especially in the elderly. By subtype, influenza A(H3N2) virus made the largest contribution to influenza-associated mortality.

Summary

Korean summary
계절 인플루엔자는 심각한 호흡기 합병증으로 진행할 수 있어 질병 부담의 추산이 중요한 질병이다. 현재까지는 연령별, 인플루엔자 연관 사망을 정확하게 추산하기 어려웠으나, 본 연구에서는 이를 추산하기 위해 고안된 다양한 방법 중 음이항 회귀 분석을 이용하여 2009년부터 2016년간 인플루엔자 아형별 연관 사망을 추산하였다. 그 결과, 전체 사망자 중 65세 미만에서 약 6,774명, 65세 이상에서 약 30,414명의 연간 인플루엔자 사망이 추산되었고, 이는 특히 인플루엔자 아형 중 전체 연령에서 A(H3N2) 연관 사망이 가장 많은 비율을 차지했다.

Citations

Citations to this article as recorded by

Influenza vaccination before and during the COVID-19 pandemic in the elderly in South Korea
Dong Jun Kim, Kyoung Hee Cho, Seongju Kim, Hooyeon Lee
Journal of Infection and Public Health.2024; 17(3): 503. CrossRef
An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014–2022) Following the Introduction of GSK’s Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Mo
Gaël Dos Santos, Raghavendra Devadiga, Chun Soo Kim, Joon Bang
Drug Safety.2024; 47(4): 365. CrossRef
Incidence, Severity, and Mortality of Influenza During 2010–2020 in Korea: A Nationwide Study Based on the Population-Based National Health Insurance Service Database
Soo-Hee Hwang, Hyejin Lee, Myunghoo Jung, Sang-Hyun Kim, Ho Kyung Sung, Myoung-don Oh, Jin Yong Lee
Journal of Korean Medical Science.2023;[Epub] CrossRef
Impact of the COVID-19 Pandemic on Influenza Vaccination and Associated Factors among Pregnant Women: A Cross-Sectional Study in Korea
Boyeon Kim, Eunyoung Kim
Vaccines.2023; 11(3): 512. CrossRef
Influenza Vaccination Rate and Related Factors in Korean Adults During the Coronavirus Disease 2019 Epidemic
Kyung Wan Kwon, Ka Hyeon Bae, Jeong Hwan Park, Tae Oh Kim, Jin Young Kim, Seung Min Baek, Sang Hyun Park, Ju Young Lee, Bo Hyun Park, Mi Ah Han
Asia Pacific Journal of Public Health.2023; 35(2-3): 217. CrossRef
Post-Marketing Safety Surveillance of Quadrivalent Influenza Vaccine (VaxigripTetra) in Children Aged 6 to 35 Months in South Korea
Sunho Choe, Oxana Talanova, Sooyoun Shin, Olga Syrkina, Marion Fournier
Infectious Diseases and Therapy.2023; 12(6): 1715. CrossRef
All-Cause and Cause-Specific Mortality Attributable to Seasonal Influenza: A Nationwide Matched Cohort Study
Heeseon Jang, Jaelim Cho, Seong-Kyung Cho, Donghan Lee, Sung-il Cho, Sang-Baek Koh, Dong-Chun Shin, Changsoo Kim
Journal of Korean Medical Science.2023;[Epub] CrossRef
Global trends of seasonal influenza-associated mortality in 2001–2018: A longitudinal epidemiological study
Hideharu Hagiya, Yuka Osaki, Michio Yamamoto, Takahiro Niimura, Ko Harada, Tsukasa Higashionna, Hirofumi Hamano, Yoshito Zamami, Shiro Hinotsu, Toshihiro Koyama
Journal of Infection.2023; 87(3): e54. CrossRef
Analysis of the effectiveness of non-pharmaceutical interventions on influenza during the Coronavirus disease 2019 pandemic by time-series forecasting
Hyun Kyung Kim, Kyung-Duk Min, Sung-il Cho
BMC Infectious Diseases.2023;[Epub] CrossRef
Systematic review of influenza vaccine effectiveness against laboratory-confirmed influenza among older adults living in aged care facilities
Aye Moa, Mohana Kunasekaran, Zubair Akhtar, Valentina Costantino, C. Raina MacIntyre
Human Vaccines & Immunotherapeutics.2023;[Epub] CrossRef
The Influence of Gaseous Pollutants Concentration on Influenza Outbreak Risk
晓璐马
Open Journal of Natural Science.2023; 11(06): 1003. CrossRef
The impact of free vaccination policies under the Korean Influenza National Immunization Program: Trends in influenza vaccination rates in South Korea from 2010 to 2019
Jeongmin Seo, Juwon Lim, Dong Keon Yon
PLOS ONE.2022; 17(1): e0262594. CrossRef
Post-marketing Surveillance of a Quadrivalent Influenza Vaccine (Vaxigrip Tetra) in South Korea
Sookyung Lim, Xiaoling Li, Olga Syrkina, Marion Fournier
Infectious Diseases and Therapy.2022; 11(5): 2035. CrossRef
Novel respiratory infectious diseases in Korea
Hyun Jung Kim
Yeungnam University Journal of Medicine.2020; 37(4): 286. CrossRef

Special Article

Strategies for Appropriate Patient-centered Care to Decrease the Nationwide Cost of Cancers in Korea: Jong-Myon Bae; J Prev Med Public Health. 2017;50(4):217-227. Published online June 16, 2017; DOI: https://doi.org/10.3961/jpmph.17.069

6,545 View
158 Download
2 Crossref

Abstract PDF Supplementary Material

In terms of years of life lost to premature mortality, cancer imposes the highest burden in Korea. In order to reduce the burden of cancer, the Korean government has implemented cancer control programs aiming to reduce cancer incidence, to increase survival rates, and to decrease cancer mortality. However, these programs may paradoxically increase the cost burden. For examples, a cancer screening program for early detection could bring about over-diagnosis and over-treatment, and supplying medical services in a paternalistic manner could lead to defensive medicine or futile care. As a practical measure to reduce the cost burden of cancer, appropriate cancer care should be established. Ensuring appropriateness requires patient-doctor communication to ensure that utility values are shared and that autonomous decisions are made regarding medical services. Thus, strategies for reducing the cost burden of cancer through ensuring appropriate patient-centered care include introducing value-based medicine, conducting cost-utility studies, and developing patient decision aids.

Summary

Citations

Citations to this article as recorded by

A Systematic Review of Economic Evaluation of Thyroid Cancer
Mijin Kim, Woojin Lim, Kyungsik Kim, Ja Seong Bae, Byung Joo Lee, Bon Seok Koo, Eun Kyung Lee, Eu Jeong Ku, June Young Choi, Bo Hyun Kim, Sue K. Park
International Journal of Thyroidology.2022; 15(2): 74. CrossRef
Ethical, pedagogical, socio-political and anthropological implications of quaternary prevention
Marc Jamoulle, Michel Roland, Jong-Myon Bae, Bruno Heleno, Giorgio Visentin, Gustavo Diniz Ferreira Gusso, Maciek Godycki-Ćwirko, Miguel Pizzanell, Patrick Ouvrard, Ricardo La Valle, Luis Filipe Gomes, Daniel Widmer, Jorge Bernstein, Mariana Mariño, Hamil
Revista Brasileira de Medicina de Família e Comunidade.2018; 13(40): 1. CrossRef

Original Articles

Economic Burden of Colorectal Cancer in Korea: Ju-Young Byun, Seok-Jun Yoon, In-Hwan Oh, Young Ae Kim, Hye-Young Seo, Yo-Han Lee; J Prev Med Public Health. 2014;47(2):84-93. Published online March 31, 2014; DOI: https://doi.org/10.3961/jpmph.2014.47.2.84

14,382 View
143 Download
17 Crossref

Abstract PDF

Objectives

The incidence and survival rate of colorectal cancer in Korea are increasing because of improved screening, treatment technologies, and lifestyle changes. In this aging population, increases in economic cost result. This study was conducted to estimate the economic burden of colorectal cancer utilizing claims data from the Health Insurance Review and Assessment Service.

Methods

Economic burdens of colorectal cancer were estimated using prevalence data and patients were defined as those who received ambulatory treatment from medical institutions or who had been hospitalized due to colorectal cancer under the International Classification of Disease 10th revision codes from C18-C21. The economic burdens of colorectal cancer were calculated as direct costs and indirect costs.

Results

The prevalence rate (per 100 000 people) of those who were treated for colorectal cancer during 2010 was 165.48. The economic burdens of colorectal cancer in 2010 were 3 trillion and 100 billion Korean won (KRW), respectively. Direct costs included 1 trillion and 960 billion KRW (62.85%), respectively and indirect costs were 1 trillion and 160 billion (37.15%), respectively.

Conclusions

Colorectal cancer has a large economic burden. Efforts should be made to reduce the economic burden of the disease through primary and secondary prevention.

Summary

Citations

Citations to this article as recorded by

Estimating the economic burden of colorectal cancer in China, 2019–2030: A population‐level prevalence‐based analysis
Hong Wang, Yan‐Jie Li, Lin Lei, Cheng‐Cheng Liu, Wan‐Qing Chen, Min Dai, Xin Wang, Jie‐Bin Lew, Ju‐Fang Shi, Ni Li, Jie He
Cancer Medicine.2024;[Epub] CrossRef
Cost of illness for colorectal cancer in Japan - a time trend and future projections (1996–2035) based on governmental statistics
Kunichika Matsumoto, Yosuke Hatakeyama, Kanako Seto, Ryo Onishi, Koki Hirata, Yinghui Wu, Tomonori Hasegawa
BMC Health Services Research.2023;[Epub] CrossRef
Colorectal cancer-related resource utilization and healthcare costs in Saudi Arabia
Bander Balkhi, Ahmed Alghamdi, Saeed Alqahtani, Marwan Al Najjar, Abdullah Al Harbi, Thamer Bin Traiki
Saudi Pharmaceutical Journal.2023; 31(11): 101822. CrossRef
A performance measurement framework for socially sustainable and resilient supply chains using environmental goods valuation methods
Aref A. Hervani, Santosh Nandi, Marilyn M. Helms, Joseph Sarkis
Sustainable Production and Consumption.2022; 30: 31. CrossRef
Direct medical costs of young-onset colorectal cancer: a worldwide systematic review
Ria Garg, Vicki Cheng, Ursula Ellis, Vanay Verma, Helen McTaggart-Cowan, Stuart Peacock, Jonathan M. Loree, Mohsen Sadatsafavi, Mary A. De Vera
BMC Health Services Research.2022;[Epub] CrossRef
Economic Burden of Colorectal Cancer: A Case of Fars, Iran
Abdosaleh Jafari, Peyman Mehdi Alamdarloo, Mehdi Dehghani, Peivand Bastani, Ramin Ravangard
Cancer Control.2021; 28: 107327482110099. CrossRef
Quality of life and costs of patients prior to colorectal surgery
M. Pattamatta, B. J. J. Smeets, S. M. A. A. Evers, E. G. Peters, M. D. P. Luyer, M. Hiligsmann
Expert Review of Pharmacoeconomics & Outcomes Research.2020; 20(2): 193. CrossRef
Socioeconomic Burden of Cancer in Korea from 2011 to 2015
Young Ae Kim, Ye-Rin Lee, Jeongjoo Park, In-Hwan Oh, Hoseob Kim, Seok-Jun Yoon, Keeho Park
Cancer Research and Treatment.2020; 52(3): 896. CrossRef
The Direct and Indirect Costs of Colorectal Cancer in Vietnam: An Economic Analysis from a Social Perspective
Binh Thang Tran, Kui Son Choi, Thanh Xuan Nguyen, Dae Kyung Sohn, Sun-Young Kim, Jae Kyung Suh, Van Sang Phan, Huu Tri Pham, Minh Hanh Nguyen, Thanh Binh Nguyen, Huu Khoi Hoang, Thi Thanh Binh Nguyen, Minh Tu Nguyen, Jin-Kyoung Oh
International Journal of Environmental Research and Public Health.2020; 18(1): 12. CrossRef
Emerging hazard effects of proton pump inhibitor on the risk of colorectal cancer in low-risk populations: A Korean nationwide prospective cohort study
In Cheol Hwang, Jooyoung Chang, Sang Min Park, Suminori Akiba
PLOS ONE.2017; 12(12): e0189114. CrossRef
Analysis of Productivity Costs in Cancer: A Systematic Review
Jordi Gol-Montserrat, María Luisa M. del Burgo, Luis Quecedo, Juan E. del Llano
Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish.2017; 4(1): grhta.5000262. CrossRef
The Economic Burden of Hepatitis A, B, and C in South Korea
Changwoo Shon, Hyung-Yun Choi, Jae-Jun Shim, So-Youn Park, Kyung Suk Lee, Seok-Jun Yoon, In-Hwan Oh
Japanese Journal of Infectious Diseases.2016; 69(1): 18. CrossRef
Dehydroglyasperin D Inhibits the Proliferation of HT-29 Human Colorectal Cancer Cells Through Direct Interaction With Phosphatidylinositol 3-kinase
Sung Keun Jung, Chul-Ho Jeong
Journal of Cancer Prevention.2016; 21(1): 26. CrossRef
The Economic Burden of Cancer in Korea in 2009
So Young Kim, Jong-Hyock Park, Kyoung Hee Kang, Inuk Hwang, Hyung Kook Yang, Young-Joo Won, Hong-Gwan Seo, Dukhyoung Lee, Seok-Jun Yoon
Asian Pacific Journal of Cancer Prevention.2015; 16(3): 1295. CrossRef
The Economic Burden of Cancers Attributable to Metabolic Syndrome in Korea
Dongwoo Kim, Seok-Jun Yoon, Young-Hoon Gong, Young Ae Kim, Hye-Young Seo, Jihyun Yoon, A-Rim Kim
Journal of Preventive Medicine and Public Health.2015; 48(4): 180. CrossRef
Trends in Colorectal Cancer Incidence in Daejeon and Chungcheongnam-do, South Korea (2000-2012)
Soon-Young Kim, In-Sun Kweon, Jung-A Kim, Tae-Yong Lee, Hae-Sung Nam
Journal of agricultural medicine and community health.2015; 40(3): 115. CrossRef
FOXM1-mediated downregulation of uPA and MMP9 by 3,3′-diindolylmethane inhibits migration and invasion of human colorectal cancer cells
HUA JIN, XIU JUAN LI, MAN HEE PARK, SOO MI KIM
Oncology Reports.2015; 33(6): 3171. CrossRef

The Economic Burden of Epilepsy in Korea, 2010: Jaehun Jung, Hye-Young Seo, Young Ae Kim, In-Hwan Oh, Yo Han Lee, Seok-Jun Yoon; J Prev Med Public Health. 2013;46(6):293-299. Published online November 28, 2013; DOI: https://doi.org/10.3961/jpmph.2013.46.6.293

9,689 View
126 Download
10 Crossref

Abstract PDF

Objectives

The purposes of this study were to evaluate the prevalence of epilepsy and to estimate the cost of epilepsy in Korea, 2010.

Methods

This study used a prevalence based approach to calculate the cost of epilepsy. Claims data from the Korean national health insurance and data from the Korea health panel, the Korea National Statistical Office's records of causes of death, and labor statistics were used to estimate the cost of epilepsy. Patients were defined as those who were hospitalized or visited an outpatient clinic during 2010 with a diagnosis of epilepsy (International Classification of Diseases 10th revision codes G40-G41). Total costs of epilepsy included direct medical costs, direct non-medical cost and indirect costs.

Results

The annual prevalence of treated epilepsy was 228 per 100 000 population, and higher in men. The age-specific prevalence was highest for teenagers. The total economic burden of epilepsy was 536 billion Korean won (KW). Indirect cost (304 billion KW) was 1.3 times greater than direct cost (232 billion KW). By gender, the male (347 billion KW) were more burdened than the female (189 billion KW). The estimated cost in young age younger than 20 years old was 24.5% of the total burden of epilepsy.

Conclusions

A significant portion of the economic burden of epilepsy is borne by people in young age. To reduce the economic burden of epilepsy, effective prevention and treatment strategies are needed.

Summary

Citations

Citations to this article as recorded by

Evaluation of persistence and healthcare utilization in patients treated with anti-seizure medications as add-on therapy: A nationwide cohort study in South Korea
Ji Woong Lee, Jung-Ae Kim, Min Young Kim, Sang Kun Lee
Epilepsy & Behavior.2022; 126: 108459. CrossRef
Cost of Illness of Epilepsy and Associated Factors in Patients Attending Adult Outpatient Department of University of Gondar Referral Hospital, Northwest Ethiopia
Piniel Melkamu, Yaregal Animut, Amare Minyihun, Asmamaw Atnafu, Mezgebu Yitayal
Risk Management and Healthcare Policy.2021; Volume 14: 2385. CrossRef
Cost–benefit analysis, cost-effectiveness analysis, and impact of antiepileptic drugs on the risk of fracture in patients with epilepsy: A nationwide cohort study
Hsin-Hsuan Cheng, Pei-Tseng Kung, Bo-Ren Wang, Li-Ting Chiu, Wen-Chen Tsai
Epilepsy & Behavior.2020; 103: 106851. CrossRef
Introducing big data analysis using data from National Health Insurance Service
EunJin Ahn
Korean Journal of Anesthesiology.2020; 73(3): 205. CrossRef
Epilepsy in Asia: Disease burden, management barriers, and challenges
Eugen Trinka, Patrick Kwan, ByungIn Lee, Amitabh Dash
Epilepsia.2019; 60(S1): 7. CrossRef
The Present and Future of Vagus Nerve Stimulation
Jeyul Yang, Ji Hoon Phi
Journal of Korean Neurosurgical Society.2019; 62(3): 344. CrossRef
Costs of informal nursing care for patients with neurologic disorders
Freya Diederich, Hans-Helmut König, Claudia Mietzner, Christian Brettschneider
Neurology.2018; 90(1): 28. CrossRef
The Economic Burden of Hepatitis A, B, and C in South Korea
Changwoo Shon, Hyung-Yun Choi, Jae-Jun Shim, So-Youn Park, Kyung Suk Lee, Seok-Jun Yoon, In-Hwan Oh
Japanese Journal of Infectious Diseases.2016; 69(1): 18. CrossRef
A nationwide epidemiological study of newly diagnosed spine metastasis in the adult Korean population
Seil Sohn, Jinhee Kim, Chun Kee Chung, Na Rae Lee, Eunjung Park, Ung-Kyu Chang, Moon Jun Sohn, Sung Hwan Kim
The Spine Journal.2016; 16(8): 937. CrossRef
The direct costs of epilepsy in Russia. A prospective cost-of-illness study from a single center in Moscow
Alla Guekht, Maria Mizinova, Igor Kaimovsky, Oksana Danilenko, Elisa Bianchi, Ettore Beghi
Epilepsy & Behavior.2016; 64: 122. CrossRef

The Socioeconomic Burden of Coronary Heart Disease in Korea: Hoo-Sun Chang, Han-Joong Kim, Chung-Mo Nam, Seung-Ji Lim, Young-Hwa Jang, Sera Kim, Hye-Young Kang; J Prev Med Public Health. 2012;45(5):291-300. Published online September 28, 2012; DOI: https://doi.org/10.3961/jpmph.2012.45.5.291

12,369 View
117 Download
30 Crossref

Abstract PDF

Objectives

We aimed to estimate the annual socioeconomic burden of coronary heart disease (CHD) in Korea in 2005, using the National Health Insurance (NHI) claims data.

Methods

A prevalence-based, top-down, cost-of-treatment method was used to assess the direct and indirect costs of CHD (International Classification of Diseases, 10th revision codes of I20-I25), angina pectoris (I20), and myocardial infarction (MI, I21-I23) from a societal perspective.

Results

Estimated national spending on CHD in 2005 was $2.52 billion. The majority of the spending was attributable to medical costs (53.3%), followed by productivity loss due to morbidity and premature death (33.6%), transportation (8.1%), and informal caregiver costs (4.9%). While medical cost was the predominant cost attribute in treating angina (74.3% of the total cost), premature death was the largest cost attribute for patients with MI (66.9%). Annual per-capita cost of treating MI, excluding premature death cost, was $3183, which is about 2 times higher than the cost for angina ($1556).

Conclusions

The total insurance-covered medical cost ($1.13 billion) of CHD accounted for approximately 6.02% of the total annual NHI expenditure. These findings suggest that the current burden of CHD on society is tremendous and that more effective prevention strategies are required in Korea.

Summary

Citations

Citations to this article as recorded by

Change in coronary heart disease hospitalization after chronic disease management: a programme policy in China
Jingmin Zhu, Wei Wang, Jun Wang, Liang Zhu
Health Policy and Planning.2023; 38(2): 161. CrossRef
Direct medical costs of ischemic heart disease in urban Southern China: a 5-year retrospective analysis of an all-payer health claims database in Guangzhou City
Peixuan Xie, Xuezhu Li, Feifan Guo, Donglan Zhang, Hui Zhang
Frontiers in Public Health.2023;[Epub] CrossRef
Hospitalization Expenses and Influencing Factors for Inpatients with Ischemic Heart Disease in Iran: A Retrospective Study
Maryam Shirvani Shiri, Sara Emamgholipour Sefiddashti, Rajabali Daroudi, Maryam Tatary, Zohreh Kazemi, Hassan Karami
Health Scope.2022;[Epub] CrossRef
Social and Economic Costs and Health-Related Quality of Life in Patients With Acute Coronary Syndrome
Saeed Sheikhgholami, Farbod Ebadifardazar, Aziz Rezapoor, Masih Tajdini, Mojtaba Salarifar
Value in Health Regional Issues.2021; 24: 123. CrossRef
Epidemiology of cardiovascular disease and its risk factors in Korea
Hyeon Chang Kim
Global Health & Medicine.2021; 3(3): 134. CrossRef
Prevalence and socioeconomic burden of diabetes mellitus in South Korean adults: a population-based study using administrative data
Sung-Hee Oh, Hyemin Ku, Kang Seo Park
BMC Public Health.2021;[Epub] CrossRef
Cost-Effectiveness Analysis of Positive Airway Pressure in Patient with Obstructive Sleep Apnea
Hansol Kim, Jin Kook Kim, Jae Hoon Cho
Journal of Rhinology.2021; 28(2): 94. CrossRef
Health-economic burden of dementia in South Korea
Changwoo Shon, Hyejung Yoon
BMC Geriatrics.2021;[Epub] CrossRef
The economic burden of chronic diseases: Estimates and projections for China, Japan, and South Korea
David E. Bloom, Simiao Chen, Michael Kuhn, Mark E. McGovern, Les Oxley, Klaus Prettner
The Journal of the Economics of Ageing.2020; 17: 100163. CrossRef
Achievement of the low-density lipoprotein cholesterol goal among patients with dyslipidemia in South Korea
Siin Kim, Sola Han, Pratik P. Rane, Yi Qian, Zhongyun Zhao, Hae Sun Suh, Luigina Guasti
PLOS ONE.2020; 15(1): e0228472. CrossRef
Direct and Indirect Costs Associated with Coronary Artery (Heart) Disease in Tabriz, Iran

Shahla Darba, Naser Safaei, Alireza Mahboub–Ahari, Shirin Nosratnejad, Gisoo Alizadeh, Hosein Ameri, Mahmood Yousefi
Risk Management and Healthcare Policy.2020; Volume 13: 969. CrossRef
Estimation of the Economic Burden of Cardiovascular Diseases in Selected Hospitals of Yazd in 2018
Mohsen Pakdaman, Sara Gravandi, Roohollah Askari, Milad Shafii, Mahdieh Khaleghi Muri, Sajjad Bahariniya
Qom Univ Med Sci J.2020; 14(7): 58. CrossRef
Socioeconomic Costs of Age-related Macular Degeneration in Korea
Yongsun Ahn, Donghyun Jee
Journal of the Korean Ophthalmological Society.2019; 60(8): 765. CrossRef
Association of Thyroid-Stimulating Hormone and Thyroid Hormones with Cardiometabolic Risk Factors in Euthyroid Children and Adolescents Aged 10–18 Years: A Population-Based Study
Cheol Gyu Ma, Young Suk Shim
Scientific Reports.2019;[Epub] CrossRef
Utilization Patterns of Lipid-lowering Therapies in Patients With Atherosclerotic Cardiovascular Disease or Diabetes: A Population-based Study in South Korea
Siin Kim, Hyungtae Kim, Eunju Kim, Sola Han, Pratik P. Rane, Kathleen M. Fox, Zhongyun Zhao, Yi Qian, Hae Sun Suh
Clinical Therapeutics.2018; 40(6): 940. CrossRef
Sex differences in discharge destination following acute myocardial infarction
Leor Perl, Véronique Peiffer, Audelia E. Fuhrer, Fabrizio D’Ascenzo, Jan B. Pietzsch
Coronary Artery Disease.2018; 29(6): 502. CrossRef
Prevalence and severity of coronary artery calcification based on the epidemiologic pattern: A propensity matched comparison of asymptomatic Korean and Chinese adults
Donghee Han, Yang Gao, Bríain ó Hartaigh, Heidi Gransar, Ji Hyun Lee, Asim Rizvi, Su-Yeon Choi, Eun Ju Chun, Jidong Sung, Hae-Won Han, Sung Hak Park, James K. Min, Bin Lu, Hyuk-Jae Chang
International Journal of Cardiology.2017; 230: 353. CrossRef
Economic burden of chronic kidney disease in Korea using national sample cohort
Seon-Ha Kim, Min-Woo Jo, Dun-Sol Go, Dong-Ryeol Ryu, Jongha Park
Journal of Nephrology.2017; 30(6): 787. CrossRef
Cost effectiveness of influenza vaccination in patients with acute coronary syndrome in Korea
Jinuk Suh, Boyeon Kim, Yunseok Yang, Dong-Churl Suh, Eunyoung Kim
Vaccine.2017; 35(21): 2811. CrossRef
A nationwide epidemiological study of newly diagnosed spine metastasis in the adult Korean population
Seil Sohn, Jinhee Kim, Chun Kee Chung, Na Rae Lee, Eunjung Park, Ung-Kyu Chang, Moon Jun Sohn, Sung Hwan Kim
The Spine Journal.2016; 16(8): 937. CrossRef
Reference Values for The Triglyceride to High-Density Lipoprotein Cholesterol Ratio and Non-High-Density Lipoprotein Cholesterol in Korean Children and Adolescents: The Korean National Health and Nutrition Examination Surveys 2007-2013
Young Suk Shim, Joon Woo Baek, Min Jae Kang, Yeon Jeong Oh, Seung Yang, II Tae Hwang
Journal of Atherosclerosis and Thrombosis.2016; 23(12): 1334. CrossRef
Prevalence and Distribution of Coronary Artery Calcification in Asymptomatic United States and Korean Adults　– Cross-Sectional Propensity-Matched Analysis –
Donghee Han, Bríain ó Hartaigh, Heidi Gransar, Ji Hyun Lee, Su-Yeon Choi, Eun Ju Chun, Jidong Sung, Hae-Won Han, Sung Hak Park, Tracy Callister, Fay Y. Lin, James K. Min, Hyuk-Jae Chang
Circulation Journal.2016; 80(11): 2349. CrossRef
Productivity losses associated with cardiovascular disease: a systematic review
Adam L Gordois, Peter P Toth, Ruben GW Quek, Emma M Proudfoot, Carly J Paoli, Shravanthi R Gandra
Expert Review of Pharmacoeconomics & Outcomes Research.2016; 16(6): 759. CrossRef
Trends in lipid profiles among South Korean adults: 2005, 2008 and 2010 Korea National Health and Nutrition Examination Survey
Ga Eun Nam, Kyungdo Han, Yong Gyu Park, Youn Seon Choi, Seon Mee Kim, Sang-Yhun Ju, Byung-Joon Ko, Yang Hyun Kim, Eun Hye Kim, Kyung Hwan Cho, Do Hoon Kim
Journal of Public Health.2015; 37(2): 286. CrossRef
Economic burden and cost determinants of coronary heart disease in rural southwest China: a multilevel analysis
C. Le, Y. Fang, W. Linxiong, Z. Shulan, A.R. Golden
Public Health.2015; 129(1): 68. CrossRef
Factors Predicting Nutrition and Physical Activity Behaviors Due to Cardiovascular Disease in Tehran University Students: Application of Health Belief Model
Fatemeh Rahmati Najarkolaei, Sedigheh Sadat Tavafian, Mohammad Gholami Fesharaki, Mohammad Reza Jafari
Iranian Red Crescent Medical Journal.2015;[Epub] CrossRef
Admission route and use of invasive procedures during hospitalization for acute myocardial infarction: analysis of 2007-2011 National Health Insurance database
Hyungseon Yeom, Dae Ryong Kang, Seong Kyung Cho, Seung Won Lee, Dong-Ho Shin, Hyeon Chang Kim
Epidemiology and Health.2015; 37: e2015022. CrossRef
Recent Trends in Economic Burden of Acute Myocardial Infarction in South Korea
Hyeyoung Seo, Seok-Jun Yoon, Jihyun Yoon, Dongwoo Kim, Younghoon Gong, A. Rim Kim, In-Hwan Oh, Eun-Jung Kim, Yo-Han Lee, Chiara Lazzeri
PLOS ONE.2015; 10(2): e0117446. CrossRef
The Economic Burden of Self-Reported and Undiagnosed Cardiovascular Diseases and Diabetes on Indonesian Households
Eric A. Finkelstein, Junxing Chay, Shailendra Bajpai, Ajay Mahal
PLoS ONE.2014; 9(6): e99572. CrossRef
The Incidence and Prevalence of Diabetes Mellitus and Related Atherosclerotic Complications in Korea: A National Health Insurance Database Study
Bo Kyung Koo, Chang-Hoon Lee, Bo Ram Yang, Seung-sik Hwang, Nam-Kyong Choi, Mohammad Ebrahim Khamseh
PLoS ONE.2014; 9(10): e110650. CrossRef

English Abstracts

Socioeconomic Costs of Food-Borne Disease Using the Cost-of-Illness Model: Applying the QALY Method.: Hosung Shin, Suehyung Lee, Jong Soo Kim, Jinsuk Kim, Kyu Hong Han; J Prev Med Public Health. 2010;43(4):352-361.; DOI: https://doi.org/10.3961/jpmph.2010.43.4.352

5,350 View
123 Download
20 Crossref

Abstract PDF

OBJECTIVES
This study estimated the annual socioeconomic costs of food-borne disease in 2008 from a societal perspective and using a cost-of-illness method. METHODS: Our model employed a comprehensive set of diagnostic disease codes to define food-borne diseases with using the Korea National Health Insurance (KNHI) reimbursement data. This study classified the food borne illness as three types of symptoms according to the severity of the illness: mild, moderate, severe. In addition to the traditional method of assessing the cost-of-illness, the study included measures to account for the lost quality of life. We estimated the cost of the lost quality of life using quality-adjusted life years and a visual analog scale. The direct cost included medical and medication costs, and the non-medical costs included transportation costs, caregiver's cost and administration costs. The lost productivity costs included lost workdays due to illness and lost earnings due to premature death. RESULTS: The study found the estimated annual socioeconomic costs of food-borne disease in 2008 were 954.9 billion won (735.3 billion won-996.9 billion won). The medical cost was 73.4 - 76.8% of the cost, the lost productivity cost was 22.6% and the cost of the lost quality of life was 26.0%. CONCLUSIONS: Most of the cost-of-illness studies are known to have underestimated the actual socioeconomic costs of the subjects, and these studies excluded many important social costs, such as the value of pain, suffering and functional disability. The study addressed the uncertainty related to estimating the socioeconomic costs of food-borne disease as well as the updated cost estimates. Our estimates could contribute to develop and evaluate policies for food-borne disease.

Summary

Citations

Citations to this article as recorded by

Evaluation of Health Economic Loss Due to Particulate Matter Pollution in the Seoul Subway, South Korea
Prakash Thangavel, Kyoung Youb Kim, Duckshin Park, Young-Chul Lee
Toxics.2023; 11(2): 113. CrossRef
Risk and socio-economic impact for Staphylococcus aureus foodborne illness by ready-to-eat salad consumption
Yewon Lee, Hyemin Oh, Yeongeun Seo, Joohyun Kang, Eunyoung Park, Yohan Yoon
Microbial Risk Analysis.2022; 21: 100219. CrossRef
Risk assessment for norovirus foodborne illness by raw oyster (Ostreidae) consumption and economic burden in Korea
Yoonjeong Yoo, Hyemin Oh, Yewon Lee, Miseon Sung, Jeongeun Hwang, Ziwei Zhao, Sunho Park, Changsun Choi, Yohan Yoon
Fisheries and Aquatic Sciences.2022; 25(5): 287. CrossRef
Does information on food safety affect consumers' acceptance of new food technologies? The case of irradiated beef in South Korea under a new labelling system and across different information regimes
Vincenzina Caputo
Australian Journal of Agricultural and Resource Economics.2020; 64(4): 1003. CrossRef
Campylobacter control measures in indoor broiler chicken: critical re-assessment of cost-utility and putative barriers to implementation
J. G. Pitter, Z. Vokó, Á Józwiak, A. Berkics
Epidemiology and Infection.2018; 146(11): 1433. CrossRef
The monetary value of human lives lost due to neglected tropical diseases in Africa
Joses Muthuri Kirigia, Gitonga N. Mburugu
Infectious Diseases of Poverty.2017;[Epub] CrossRef
Identification of environmental determinants for spatio-temporal patterns of norovirus outbreaks in Korea using a geographic information system and binary response models
Jin Hwi Kim, Dong Hoon Lee, Yongsung Joo, Kyung Duk Zoh, Gwangpyo Ko, Joo-Hyon Kang
Science of The Total Environment.2016; 569-570: 291. CrossRef
Expert opinions on improvement of current food code related to hygiene management standards for cooked foods in restaurants
Seyoung Ju, Hyoseon Kawk, Wansoo Hong, Tongkyung Kwak, Hyeja Chang
Journal of Nutrition and Health.2016; 49(3): 201. CrossRef
Importance and Performance Analysis of Sanitation Management in Workers at Small and Medium Foodservice Industries Using HACCP Prerequisites
Hyun-Jun Lee, Wan-Soo Hong
Journal of the Korean Society of Food Science and Nutrition.2016; 45(10): 1497. CrossRef
Emulsion PCR Improves the Specificity and Sensitivity of PCR-based Pathogen Detection
Changhoon Chai
Journal of Milk Science and Biotechnology.2016; 34(1): 43. CrossRef
Cost-of-illness and disease burden of food-related pathogens in the Netherlands, 2011
Marie-Josée J. Mangen, Martijn Bouwknegt, Ingrid H.M. Friesema, Juanita A. Haagsma, Laetitia M. Kortbeek, Luqman Tariq, Margaret Wilson, Wilfrid van Pelt, Arie H. Havelaar
International Journal of Food Microbiology.2015; 196: 84. CrossRef
Analysis of Foodborne Pathogens in Food and Environmental Samples from Foodservice Establishments at Schools in Gyeonggi Province
Tae Young Oh, Seung-Youb Baek, Minseon Koo, Jong-Kyung Lee, Seung Min Kim, Kyung-Min Park, Daekeun Hwang, Hyun Jung Kim
Journal of the Korean Society of Food Science and Nutrition.2015; 44(12): 1895. CrossRef
Isothermal Target and Probe Amplification Assay for the Real-Time Rapid Detection of Staphylococcus aureus
Hyewon Shin, Minhwan Kim, Eunju Yoon, Gyoungwon Kang, Seungyu Kim, Aelee Song, Jeongsoon Kim
Journal of Food Protection.2015; 78(4): 723. CrossRef
Next steps to evidence-based food safety risk analysis: opportunities for health technology assessment methodology implementation
János G. Pitter, Ákos Jóźwiak, Éva Martos, Zoltán Kaló, Zoltán Vokó
Studies in Agricultural Economics.2015; 117(3): 155. CrossRef
Disease-Outcome Trees, EQ-5D Scores, and Estimated Annual Losses of Quality-Adjusted Life Years (QALYs) for 14 Foodborne Pathogens in the United States
Michael Batz, Sandra Hoffmann, J. Glenn Morris
Foodborne Pathogens and Disease.2014; 11(5): 395. CrossRef
The economic burden of the 2009 pandemic H1N1 influenza in Korea
Yang-Woo Kim, Seok-Jun Yoon, In-Hwan Oh
Scandinavian Journal of Infectious Diseases.2013; 45(5): 390. CrossRef
Antimicrobial Effect of Various Chopping Boards against Food-borne Bacteria
Ji-Young Kim, Hyoung-Jae Lee, Jeong-Yong Cho, Hyun-Cheol Lim, Gyeong-Cheol Choi, Du-Woon Kim, Keun-Hyung Park, Jae-Hak Moon
Korean Journal of Food Science and Technology.2012; 44(1): 114. CrossRef
Effects of Dietary Supplementation of a New Probiotic CS61 Culture on Performance in Broiler Chickens
Sung-Hwan Kim, In-Chul Lee, Hyung-Seon Baek, Seong-Soo Kang, Hyoung-Chin Kim, Jin-Cheol Yoo, Jong-Choon Kim
Journal of Life Science.2012; 22(3): 340. CrossRef
Annual Cost of Illness and Quality-Adjusted Life Year Losses in the United States Due to 14 Foodborne Pathogens
Sandra Hoffmann, Michael B. Batz, J. Glenn Morris
Journal of Food Protection.2012; 75(7): 1292. CrossRef
Epidemiological Investigation for Outbreak of Food Poisoning Caused byBacillus cereusAmong the Workers at a Local Company in 2010
Kum-Bal Choi, Hyun-Sul Lim, Kwan Lee, Gyoung-Yim Ha, Kwang-Hyun Jung, Chang-Kyu Sohn
Journal of Preventive Medicine and Public Health.2011; 44(2): 65. CrossRef

Socioeconomic Costs of Stroke in Korea: Estimated from the Korea National Health Insurance Claims Database.: Seung ji Lim, Han joong Kim, Chung mo Nam, Hoo sun Chang, Young Hwa Jang, Sera Kim, Hye Young Kang; J Prev Med Public Health. 2009;42(4):251-260.; DOI: https://doi.org/10.3961/jpmph.2009.42.4.251

6,989 View
143 Download
42 Crossref

Abstract PDF

OBJECTIVES
To estimate the annual socioeconomic costs of stroke in Korea in 2005 from a societal perspective. METHODS: We identified those 20 years or older who had at least one national health insurance (NHI) claims record with a primary or a secondary diagnosis of stroke (ICD-10 codes: I60-I69, G45) in 2005. Direct medical costs of the stroke were measured from the NHI claims records. Direct non-medical costs were estimated as transportation costs incurred when visiting the hospitals. Indirect costs were defined as patients' and caregivers' productivity loss associated with office visits or hospitalization. Also, the costs of productivity loss due to premature death from stroke were calculated. RESULTS: A total of 882,143 stroke patients were identified with prevalence for treatment of stroke at 2.44%. The total cost for the treatment of stroke in the nation was estimated to be 3,737 billion Korean won (KRW) which included direct costs at 1,130 billion KRW and indirect costs at 2,606 billion KRW. The per-capita cost of stroke was 3 million KRW for men and 2 million KRW for women. The total national spending for hemorrhagic and ischemic stroke was 1,323 billion KRW and 1,553 billion KRW, respectively, which together consisted of 77.0% of the total cost for stroke. Costs per patient for hemorrhagic and ischemic stroke were estimated at 6 million KRW and 2 million KRW, respectively. CONCLUSIONS: Stroke is a leading public health problem in Korea in terms of the economic burden. The indirect costs were identified as the largest component of the overall cost.

Summary

Citations

Citations to this article as recorded by

Healthcare expenditure trends among adult stroke patients in the United States, 2011-2020
Venkataraghavan Ramamoorthy, Kelvin Chan, Mukesh Roy, Anshul Saxena, Md Ashfaq Ahmed, Zhenwei Zhang, Sandeep Appunni, Ronnie Thomas, Peter McGranaghan, Michael McDermott, Felipe De Los Rios La Rosa, Muni Rubens
Journal of Stroke and Cerebrovascular Diseases.2023; 32(10): 107333. CrossRef
Meta-analysis of risk factors associated with suicidal ideation after stroke
Shuangmei Zhang, Anrong Wang, Weifeng Zhu, Zhaoyang Qiu, Zhaoxu Zhang
Annals of General Psychiatry.2022;[Epub] CrossRef
Associations of stroke with all-cause and cause-specific mortality: A population-based matched cohort study
Juyeong Kim, Eun-Cheol Park
Journal of Public Health.2022;[Epub] CrossRef
Association between Stroke and Abdominal Obesity in the Middle-Aged and Elderly Korean Population: KNHANES Data from 2011–2019
Jong Yeon Kim, Sung Min Cho, Youngmin Yoo, Taesic Lee, Jong Koo Kim
International Journal of Environmental Research and Public Health.2022; 19(10): 6140. CrossRef
The risk for future cerebrovascular disease in pregnant women with Moyamoya disease: a nationwide population-based study in South Korea
Yeonseong Jeong, Yun Ji Jung, Eunjin Noh, Sungyeon Ha, Jeongeun Hwang, Geum Joon Cho, Min-Jeong Oh, Young-Han Kim
BMC Pregnancy and Childbirth.2022;[Epub] CrossRef
National Trends in Medical Costs and Prognosis of Acute Ischemic Stroke Patients in Endovascular Thrombectomy Era: Analysis Using Medical Claim Data in Korea
Woo Sang Jung, Kwon-Duk Seo, Sang Hyun Suh
Neurointervention.2022; 17(3): 152. CrossRef
Relationship between Obsessive-compulsive Disorder and Overactive Bladder Syndrome
Farzad Allameh, Mahtab Motamed, Mohammad Poury, Ali Tayyebiazar, Saleh Ghiasy, Morteza Fallah-Karkan, Saba Faraji, Seyyed Ali Hojjati
Iranian Journal of Psychiatry and Behavioral Sciences.2021;[Epub] CrossRef
Prevalence and socioeconomic burden of diabetes mellitus in South Korean adults: a population-based study using administrative data
Sung-Hee Oh, Hyemin Ku, Kang Seo Park
BMC Public Health.2021;[Epub] CrossRef
The economic burden of chronic diseases: Estimates and projections for China, Japan, and South Korea
David E. Bloom, Simiao Chen, Michael Kuhn, Mark E. McGovern, Les Oxley, Klaus Prettner
The Journal of the Economics of Ageing.2020; 17: 100163. CrossRef
Predictive costs in medical care for Koreans with metabolic syndrome from 2009 to 2013 based on the National Health Insurance claims dataset
Jeong Seon Yoo, Eun Yeong Choe, Yoo Mee Kim, Se Hwa Kim, Young Jun Won
The Korean Journal of Internal Medicine.2020; 35(4): 936. CrossRef
Lifetime risks and health impacts of hemorrhagic and ischemic stroke in South Korea
Soyeon Cheon, Hyangsook Lee, Jiyoon Won, Bo-Hyoung Jang, Jung-Der Wang
Scientific Reports.2020;[Epub] CrossRef
Comparative Study on the Outcome of Stroke Patients Transferred by Doctor Helicopters and Ground Ambulances in South Korea: A Retrospective Controlled Study
Jeong Il Lee, Kang Hyun Lee, Oh Hyun Kim, Roberto Cirocchi
Emergency Medicine International.2020; 2020: 1. CrossRef
Propensity score matching analysis on inpatient period differences of hemorrhagic stroke survivors depending on medical insurance coverage
Sang-Mi Kim, Young Kim, Seong-A Lee
Physical Therapy Rehabilitation Science.2019; 8(2): 67. CrossRef
Socioeconomic Costs of Age-related Macular Degeneration in Korea
Yongsun Ahn, Donghyun Jee
Journal of the Korean Ophthalmological Society.2019; 60(8): 765. CrossRef
Disability Measurement for Korean Community-Dwelling Adults With Stroke: Item-Level Psychometric Analysis of the Korean Longitudinal Study of Ageing
Ickpyo Hong, Young Joo Kim, Mandi L. Sonnenfeld, Emily Grattan, Timothy A. Reistetter
Annals of Rehabilitation Medicine.2018; 42(2): 336. CrossRef
The Economic Burden of Stroke Based on South Korea’s National Health Insurance Claims Database
Yu-Jin Cha
International Journal of Health Policy and Management.2018; 7(10): 904. CrossRef
Changing Disease Trends in the Northern Gyeonggi-do Province of South Korea from 2002 to 2013: A Big Data Study Using National Health Information Database Cohort
Young Soo Kim, Dong-Hee Lee, Hiun Suk Chae, Kyungdo Han
Osong Public Health and Research Perspectives.2018; 9(5): 248. CrossRef
A Nation-Wide Epidemiological Study of Newly Diagnosed Primary Spine Tumor in the Adult Korean Population, 2009-2011
Seil Sohn, Jinhee Kim, Chun Kee Chung, Na Rae Lee, Moon Jun Sohn, Sung Hwan Kim
Journal of Korean Neurosurgical Society.2017; 60(2): 195. CrossRef
Analysis of Total Hospital Charges, Length of Stay, and Cost of Rehabilitation by Hospital and Stroke Type
Sun-Mi Kim, Da-Yang Kim, Kwang-Soo Lee
The Korean Journal of Health Service Management.2017; 11(1): 91. CrossRef
The Economic Burden of Hepatitis A, B, and C in South Korea
Changwoo Shon, Hyung-Yun Choi, Jae-Jun Shim, So-Youn Park, Kyung Suk Lee, Seok-Jun Yoon, In-Hwan Oh
Japanese Journal of Infectious Diseases.2016; 69(1): 18. CrossRef
Validation of Stroke and Thrombolytic Therapy in Korean National Health Insurance Claim Data
Tai Hwan Park, Jay Chol Choi
Journal of Clinical Neurology.2016; 12(1): 42. CrossRef
Suicidal ideation and attempts in patients with stroke: a population-based study
Jae Ho Chung, Jung Bin Kim, Ji Hyun Kim
Journal of Neurology.2016; 263(10): 2032. CrossRef
The Epidemiology and Economic Burden ofClostridium difficileInfection in Korea
Hyung-Yun Choi, So-Youn Park, Young-Ae Kim, Tai-Young Yoon, Joong-Myung Choi, Bong-Keun Choe, So-Hee Ahn, Seok-Jun Yoon, Ye-Rin Lee, In-Hwan Oh
BioMed Research International.2015; 2015: 1. CrossRef
Antithrombotic treatment for stroke prevention in atrial fibrillation: The Asian agenda
Chen-Huan Chen, Mien-Cheng Chen, Harry Gibbs, Sun U. Kwon, Sidney Lo, Young Keun On, Azhari Rosman, Nijasri C. Suwanwela, Ru San Tan, Louie S. Tirador, Andreas Zirlik
International Journal of Cardiology.2015; 191: 244. CrossRef
Nationwide epidemiology and healthcare utilization of spine tumor patients in the adult Korean population, 2009–2012
Seil Sohn, Jinhee Kim, Chun Kee Chung, Na-Rye Lee, Eunjung Park, Ung-Kyu Chang, Moon Jun Sohn, Sung Hwan Kim
Neuro-Oncology Practice.2015; 2(2): 93. CrossRef
Direct medical cost of stroke in Singapore
Charmaine Shuyu Ng, Matthias Paul Han Sim Toh, Jiaying Ng, Yu Ko
International Journal of Stroke.2015; 10(SA100): 75. CrossRef
Clinical characteristics of patients with treated epilepsy in Korea: A nationwide epidemiologic study
Dong Wook Kim, Seo‐Young Lee, Soo‐Eun Chung, Hae‐Kwan Cheong, Ki‐Young Jung
Epilepsia.2014; 55(1): 67. CrossRef
The association between inhaled long-acting bronchodilators and less in-hospital care in newly-diagnosed COPD patients
Jinhee Kim, Kyungjoo Kim, Yuri Kim, Kwang-Ha Yoo, Chin Kook Lee, Hyoung Kyu Yoon, Young Sam Kim, Young Bum Park, Jin Hwa Lee, Yeon-Mok Oh, Sang-Do Lee, Sei Won Lee
Respiratory Medicine.2014; 108(1): 153. CrossRef
Medical Utilization and Cost in Patients with Overlap Syndrome of Chronic Obstructive Pulmonary Disease and Asthma
Chin Kook Rhee, Hyoung Kyu Yoon, Kwang Ha Yoo, Young Sam Kim, Sei Won Lee, Yong Bum Park, Jin Hwa Lee, Yuri Kim, Kyungjoo Kim, Jinhee Kim, Yeon Mok Oh, Sang Do Lee
COPD: Journal of Chronic Obstructive Pulmonary Disease.2014; 11(2): 163. CrossRef
The costs of hepatitis A infections in South Korea
Kyohyun Kim, Baek-Geun Jeong, Moran Ki, Mira Park, Jin Kyung Park, Bo Youl Choi, Weon-Seob Yoo
Epidemiology and Health.2014; 36: e2014011. CrossRef
The Incidence and Prevalence of Diabetes Mellitus and Related Atherosclerotic Complications in Korea: A National Health Insurance Database Study
Bo Kyung Koo, Chang-Hoon Lee, Bo Ram Yang, Seung-sik Hwang, Nam-Kyong Choi, Mohammad Ebrahim Khamseh
PLoS ONE.2014; 9(10): e110650. CrossRef
Two-Year Direct Medical Costs of Stroke in Korea: A Multi-Centre Incidence-Based Study from Hospital Perspectives
Joung-Ho Rha, Jaseong Koo, Ki Hyun Cho, Eung-Gyu Kim, Gun Sei Oh, Se Jin Lee, Jae Kwan Cha, Jin-Jeong Oh, Gyoung-Rye Ham, Hyun-Soo Seo, Jong S. Kim
International Journal of Stroke.2013; 8(3): 186. CrossRef
Stroke Statistics in Korea: Part I. Epidemiology and Risk Factors: A Report from the Korean Stroke Society and Clinical Research Center for Stroke
Keun-Sik Hong, Oh Young Bang, Dong-Wha Kang, Kyung-Ho Yu, Hee-Joon Bae, Jin Soo Lee, Ji Hoe Heo, Sun U. Kwon, Chang Wan Oh, Byung-Chul Lee, Jong S. Kim, Byung-Woo Yoon
Journal of Stroke.2013; 15(1): 2. CrossRef
The effect of severity of depressive disorder on economic burden in a university hospital in Singapore
Roger CM Ho, Kwok-Kei Mak, Anna NC Chua, Cyrus SH Ho, Anselm Mak
Expert Review of Pharmacoeconomics & Outcomes Research.2013; 13(4): 549. CrossRef
The Socioeconomic Burden of Coronary Heart Disease in Korea
Hoo-Sun Chang, Han-Joong Kim, Chung-Mo Nam, Seung-Ji Lim, Young-Hwa Jang, Sera Kim, Hye-Young Kang
Journal of Preventive Medicine and Public Health.2012; 45(5): 291. CrossRef
Prevalence of Dyslipidemia among Korean Adults: Korea National Health and Nutrition Survey 1998-2005
Myung Ha Lee, Hyeon Chang Kim, Song Vogue Ahn, Nam Wook Hur, Dong Phil Choi, Chang Gyu Park, Il Suh
Diabetes & Metabolism Journal.2012; 36(1): 43. CrossRef
Itemized Hospital Charges for Acute Cerebral Infarction Patients Influenced by Severity in an Academic Medical Center in Korea
Sung Sang Yoon, Hyejung Chang, Young Dae Kwon
Journal of Clinical Neurology.2012; 8(1): 58. CrossRef
The economic burden of stroke in 2010 in Korea
Hyun-Jin Kim, Young-Ae Kim, Hye-Young Seo, Eun-Jung Kim, Seok-Jun Yoon, In-Hwan Oh
Journal of the Korean Medical Association.2012; 55(12): 1226. CrossRef
Prevalence of Treated Epilepsy in Korea Based on National Health Insurance Data
Seo-Young Lee, Ki-Young Jung, Il Keun Lee, Sang Do Yi, Yong Won Cho, Dong Wook Kim, Seung-Sik Hwang, Sejin Kim
Journal of Korean Medical Science.2012; 27(3): 285. CrossRef
The Factors Associated with Good Responses to Speech Therapy Combined with Transcranial Direct Current Stimulation in Post-stroke Aphasic Patients
Il-Young Jung, Jong Youb Lim, Eun Kyoung Kang, Hae Min Sohn, Nam-Jong Paik
Annals of Rehabilitation Medicine.2011; 35(4): 460. CrossRef
How Much Amount of Socioeconomic Loss Is Caused by Digestive Diseases?
Kyung Sik Park
The Korean Journal of Gastroenterology.2011; 58(6): 297. CrossRef
Health Care Costs of Digestive Diseases in Korea
Hye-kyung Jung, BoHyoung Jang, Youn Hee Kim, JooYeon Park, Sun Young Park, Mi-Hee Nam, Myung-Gyu Choi
The Korean Journal of Gastroenterology.2011; 58(6): 323. CrossRef

Economic Burden of Cancer in South Korea for the Year 2005.: Jinhee Kim, Myung Il Hahm, Eun Cheol Park, Jae Hyun Park, Jong Hyock Park, Sung Eun Kim, Sung Gyeong Kim; J Prev Med Public Health. 2009;42(3):190-198.; DOI: https://doi.org/10.3961/jpmph.2009.42.3.190

6,472 View
139 Download
44 Crossref

Abstract PDF

OBJECTIVES
The objective of this study is to estimate the economic costs of cancer on society. METHODS: We estimated the economic burden of people with cancer in South Korea. To perform the analysis, we reviewed the records of people who were cancer patients and those who were newly diagnosed with cancer. The data was compiled from the National Health Insurance Corporation, which included the insurance claims database, a list of cancer patients, a database that records the cancer rates, the Korea Central Cancer Registry Center's cancer patient registry database and the Korea National Statistical Office's causes of death database. We classified the costs as related to cancer into direct costs and indirect costs, and we estimated each cost. Direct costs included both medical and non-medical care expenses and the indirect costs consisted of morbidity, mortality and the caregiver's time costs. RESULTS: The total economic costs of cancer in South Korea stood at 14.1 trillion won in 2005. The largest amount of the cost 7.4 trillion won, was the mortality costs. Following this were the morbidity costs (3.2 trillion won), the medical care costs (2.2 trillion won), the non-medical care costs (1.1 trillion won) and the costs related to the caregiver's time (100 billion won). As a result, the economic cost of cancer to South Korea is estimated to be between 11.6 trillion won to 14.1 trillion won for the year 2005. CONCLUSIONS: We need to reduce the cancer burden through encouraging people to undergo early screening for cancer and curing it in the early stage of cancer, as well as implementing policies to actively prevent cancer.

Summary

Citations

Citations to this article as recorded by

Regional Health Disparities between Mortality Rates in Three Leading Causes of Death : A Comparative Study of Spatial Dependence in Local Death Rate between Cancer, Heart Disease, and Pneumonia
Hee-Jung Jun, SeungYeoup Kang
Journal of Korea Planning Association.2023; 58(2): 38. CrossRef
Prevalence and socioeconomic burden of diabetes mellitus in South Korean adults: a population-based study using administrative data
Sung-Hee Oh, Hyemin Ku, Kang Seo Park
BMC Public Health.2021;[Epub] CrossRef
Analysis of Medical Use and Treatment Costs of Hepatocellular Carcinoma Patients Using National Patient Sample Data
Byeong-Chan Oh, Jeong-Yeon Cho, Sun-Hong Kwon, Eui-Kyung Lee, Hye-Lin Kim
Korean Journal of Clinical Pharmacy.2021; 31(2): 153. CrossRef
Sex Difference in the Socioeconomic Burden of Osteoporosis among South Koreans
Eun-Whan Lee, Jin Young Nam
Healthcare.2021; 9(10): 1304. CrossRef
Socioeconomic Burden of Disease Due to Asthma in South Korea
Eun-Whan Lee, Hee-Sun Kim, Wook Kim, Jin-Young Nam, Jae-Hyun Park
Asia Pacific Journal of Public Health.2020; 32(4): 188. CrossRef
The Economic Burden of Brain Disability in Korea, 2008-2011
Hyun-Jin Kim, Seung Hee Ho, Sol Lee, In-Hwan Oh, Ju Hee Kim, Eun Joo Kim, Seong Jae Lee
INQUIRY: The Journal of Health Care Organization, Provision, and Financing.2020; 57: 004695802093639. CrossRef
Socioeconomic Burden of Cancer in Korea from 2011 to 2015
Young Ae Kim, Ye-Rin Lee, Jeongjoo Park, In-Hwan Oh, Hoseob Kim, Seok-Jun Yoon, Keeho Park
Cancer Research and Treatment.2020; 52(3): 896. CrossRef
Measuring the Economic Burden of Disease and Injury in Korea, 2015
Ye-Rin Lee, Bogeum Cho, Min-Woo Jo, Minsu Ock, Donghoon Lee, Doungkyu Lee, Moon Jung Kim, In-Hwan Oh
Journal of Korean Medical Science.2019;[Epub] CrossRef
The economic burden of cancer attributable to obesity in Korea: A population‐based cohort study
Joo Eun Lee, Chung Mo Nam, Sang Gyu Lee, Sohee Park, Tae Hyun Kim, Eun‐Cheol Park
European Journal of Cancer Care.2019;[Epub] CrossRef
Association of Bedtime with both Suicidal Ideation and Suicide Planning among Korean Adolescents
Wonjeong Jeong, Yun Kyung Kim, Hyeon Ji Lee, Jieun Jang, Selin Kim, Eun-Cheol Park, Sung-In Jang
International Journal of Environmental Research and Public Health.2019; 16(20): 3817. CrossRef
Cancer Survivorship in Primary Care
Jihun Kang, Eun Ju Park, Jungkwon Lee
Korean Journal of Family Medicine.2019; 40(6): 353. CrossRef
The economic burden of kidney disorders in Korea
Ju Hee Kim, Seung Hee Ho, Hyun-Jin Kim, Sol Lee
Journal of Medical Economics.2018; 21(3): 262. CrossRef
How great is current curative expenditure and catastrophic health expenditure among patients with cancer in China? A research based on “System of Health Account 2011”
Ang Zheng, Wenjuan Duan, Lin Zhang, Xintong Bao, Xiaoyun Mao, Zhuojun Luo, Feng Jin
Cancer Medicine.2018; 7(8): 4036. CrossRef
The Burden of Cancer in Korea during 2012: Findings from a Prevalence-Based Approach
Young-hoon Gong, Seok-Jun Yoon, Min-Woo Jo, Arim Kim, Young Ae Kim, Jihyun Yoon, Hyeyoung Seo, Dongwoo Kim
Journal of Korean Medical Science.2016; 31(Suppl 2): S168. CrossRef
Factors Influencing the of Middle-Aged Men the NCSP(National Cancer Screening Program)
Geum-Ja Park, Kyoung-Min Lim, Sook-Nam Kim
The Korean Journal of Health Service Management.2016; 10(3): 51. CrossRef
Total costs and clinical outcome of hematopoietic stem cell transplantation in adults with leukemia: comparison between reduced‐intensity and myeloablative conditioning
Koung Jin Suh, Inho Kim, Jin Lim, Hyerim Ha, Seongyeol Park, Youngil Koh, Sung‐Soo Yoon, Seonyang Park
Clinical Transplantation.2015; 29(2): 124. CrossRef
The Epidemiology and Economic Burden ofClostridium difficileInfection in Korea
Hyung-Yun Choi, So-Youn Park, Young-Ae Kim, Tai-Young Yoon, Joong-Myung Choi, Bong-Keun Choe, So-Hee Ahn, Seok-Jun Yoon, Ye-Rin Lee, In-Hwan Oh
BioMed Research International.2015; 2015: 1. CrossRef
The Economic Burden of Cancer in Korea in 2009
So Young Kim, Jong-Hyock Park, Kyoung Hee Kang, Inuk Hwang, Hyung Kook Yang, Young-Joo Won, Hong-Gwan Seo, Dukhyoung Lee, Seok-Jun Yoon
Asian Pacific Journal of Cancer Prevention.2015; 16(3): 1295. CrossRef
The Economic Burden of Cancers Attributable to Metabolic Syndrome in Korea
Dongwoo Kim, Seok-Jun Yoon, Young-Hoon Gong, Young Ae Kim, Hye-Young Seo, Jihyun Yoon, A-Rim Kim
Journal of Preventive Medicine and Public Health.2015; 48(4): 180. CrossRef
The Economic Burden of Breast Cancer in Korea from 2007-2010
Young Ae Kim, In-Hwan Oh, Seok-Jun Yoon, Hyun-Jin Kim, Hye-Young Seo, Eun-Jung Kim, Yo Han Lee, Jae Hun Jung
Cancer Research and Treatment.2015; 47(4): 583. CrossRef
Quality of Life among End-stage Renal Disease Treatments and Economic Evaluation of Renal Transplantation and Hemodialysis Treatments
Kyung-Ock Jeon, Sun-Young Son, Myung-Il Hahm, Soon-Il Kim
Korean Journal of Transplantation.2015; 29(4): 200. CrossRef
Economic Burden of Colorectal Cancer in Korea
Ju-Young Byun, Seok-Jun Yoon, In-Hwan Oh, Young Ae Kim, Hye-Young Seo, Yo-Han Lee
Journal of Preventive Medicine and Public Health.2014; 47(2): 84. CrossRef
Attributable fraction of alcohol consumption on cancer using population-based nationwide cancer incidence and mortality data in the Republic of Korea
Sohee Park, Hai-Rim Shin, Boram Lee, Aesun Shin, Kyu-Won Jung, Duk-Hee Lee, Sun Ha Jee, Sung-Il Cho, Sue Kyung Park, Mathieu Boniol, Paolo Boffetta, Elisabete Weiderpass
BMC Cancer.2014;[Epub] CrossRef
Setting a Health Policy Research Agenda for Controlling Cancer Burden in Korea
Sung-In Jang, Kyoung-Hee Cho, Sun Jung Kim, Kwang-Sig Lee, Eun-Cheol Park
Cancer Research and Treatment.2014; 47(2): 149. CrossRef
The costs of hepatitis A infections in South Korea
Kyohyun Kim, Baek-Geun Jeong, Moran Ki, Mira Park, Jin Kyung Park, Bo Youl Choi, Weon-Seob Yoo
Epidemiology and Health.2014; 36: e2014011. CrossRef
Economic Burden of Cancer in Korea during 2000-2010
Kwang-Sig Lee, Hoo-Sun Chang, Sun-Mi Lee, Eun-Cheol Park
Cancer Research and Treatment.2014; 47(3): 387. CrossRef
Review of Tumor Dormancy Therapy Using Traditional Oriental Herbal Medicine
Jong-Ho Lee, Fan-Pei Koung, Chong-Kwan Cho, Yeon-Weol Lee, Hwa-Seung Yoo
Journal of Pharmacopuncture.2013; 16(1): 12. CrossRef
Management of Cancer Survivors in Clinical and Public Health Perspectives: Current Status and Future Challenges in Korea
Dong Wook Shin, BeLong Cho, So Young Kim, Je Hyuck Jung, Jong Hyock Park
Journal of Korean Medical Science.2013; 28(5): 651. CrossRef
Disability Weights for Cancers in Korea
Kyu Sik Choi, Jae Hyun Park, Kwang Sig Lee
Journal of Korean Medical Science.2013; 28(6): 808. CrossRef
Relationship Between Current Sleep Duration and Past Suicidal Ideation or Attempt Among Korean Adolescents
Sung-In Jang, Kwang-Sig Lee, Eun-Cheol Park
Journal of Preventive Medicine and Public Health.2013; 46(6): 329. CrossRef
Union for International Cancer Control International Session: Healthcare Economics: The significance of the UN summit non‐communicable diseases political declaration in Asia
Hideyuki Akaza, Norie Kawahara, Tohru Masui, Kunihiko Takeyama, Masafumi Nogimori, Jae Kyung Roh
Cancer Science.2013; 104(6): 773. CrossRef
A Single Measure of Cancer Burden in Korea from 1999 to 2010
Kyoung-Hee Cho, Sohee Park, Kwang-Sig Lee, Sung-In Jang, Ki-Bong Yoo, Jae-Hyun Kim, Eun-Cheol Park
Asian Pacific Journal of Cancer Prevention.2013; 14(9): 5249. CrossRef
The Socioeconomic Burden of Coronary Heart Disease in Korea
Hoo-Sun Chang, Han-Joong Kim, Chung-Mo Nam, Seung-Ji Lim, Young-Hwa Jang, Sera Kim, Hye-Young Kang
Journal of Preventive Medicine and Public Health.2012; 45(5): 291. CrossRef
Evaluation of the willingness‐to‐pay for cancer treatment in Korean metastatic breast cancer patients: A multicenter, cross‐sectional study
Do‐Youn OH, Bruce CRAWFORD, Sung‐Bae KIM, Hyun‐Cheol CHUNG, Jeffrey MCDONALD, Sang Yoon LEE, Su‐Kyoung KO, Jungsil RO
Asia-Pacific Journal of Clinical Oncology.2012; 8(3): 282. CrossRef
The economic burden of stroke in 2010 in Korea
Hyun-Jin Kim, Young-Ae Kim, Hye-Young Seo, Eun-Jung Kim, Seok-Jun Yoon, In-Hwan Oh
Journal of the Korean Medical Association.2012; 55(12): 1226. CrossRef
The Economic Burden of Inflammatory Heart Disease in Korea
Seul-Ki Ko, Seok-Jun Yoon, In-Hwan Oh, Hye-Young Seo, Eun-Jung Kim
Korean Circulation Journal.2011; 41(12): 712. CrossRef
Needs Assessment for the Beneficiaries of Home-Based Cancer Patients Management Project
Ju-Hyung Lee, Jung-Im Park, Ji-Hoon Kang, Jung-Ho Youm, Dai-Ha Koh, Keun-Sang Kwon
Journal of agricultural medicine and community health.2011; 36(4): 238. CrossRef
Socioeconomic costs of liver disease in Korea
Sunmi Lee, Woojin Chung, Kyung-Rae Hyun
The Korean Journal of Hepatology.2011; 17(4): 274. CrossRef
How Much Amount of Socioeconomic Loss Is Caused by Digestive Diseases?
Kyung Sik Park
The Korean Journal of Gastroenterology.2011; 58(6): 297. CrossRef
Comprehensive needs assessment tool in cancer (CNAT): the development and validation
Eun-Jung Shim, kyung-Sook Lee, Jong-Hyock Park, Jae-Hyun Park
Supportive Care in Cancer.2011; 19(12): 1957. CrossRef
Factors Affecting Beneficiary Satisfaction on Financial Aid Program for Cancer Patients in Korea
Ju-Ho Sim, Jong-Hyock Park, Jung-A Lee, So-Young Kim, Bo-Ram Park, Eun-Cheol Park
Korean Journal of Health Policy and Administration.2011; 21(1): 61. CrossRef
A Renal Transplantation and Hemodialysis Cost-Utility Analysis in Patients with End-Stage Renal Disease
Soon-Il Kim, Yu-Seun Kim, Myoung-Soo Kim, Eun-Cheol Park, Kyung-Ock Jeon, Sun-young Son, Myung-Il Hahm, Hoo-Yeon Lee
Korean Journal of Transplantation.2010; 24(3): 173. CrossRef
Cancer patients' need for financial assistance and its related factors
Youn-Gu Kim, Jae-Hyun Park, Jong-Hyock Park
Korean Journal of Health Policy and Administration.2010; 20(4): 58. CrossRef
Estimating Medical Expenditure Associated with Osteoporotic Hip Fracture in Elderly Korean Women Based on the National Health Insurance Claims Database 2002–2004
Hye-Young Kang, Sung-Eun Park, Dae Ryong Kang, Ji Yoon Kim, Young Hwa Jang, Won-Jung Choi, Seong-Hwan Moon, Kyu-Hyun Yang, Jin-Young Park, Soon-Yong Kwon
Value in Health.2009; 12: S93. CrossRef

Original Article

Disability Weights for the Korean Burden of Disease Study: Focused on Comparison with Disability Weights in the Australian Burden of Disease Study.: Young Kyung Do, Seok Jun Yoon, Jung Kyu Lee, Young Hoon Kwon, Sang Il Lee, Changyup Kim, Kidong Park, Yong Ik Kim, Youngsoo Shin; J Prev Med Public Health. 2004;37(1):59-71.

2,403 View
88 Download

Abstract PDF: OBJECTIVE
This study aimed to measure the disability weights for the Korean Burden of Disease study, and to compare them with those adopted in the Australian study to examine the validity and describe the distinctive features. METHODS: The standardized valuation protocol was developed from the Global Burden of Disease (GBD) study and the Dutch Disability Weights study. Disability weights were measured for 123 diseases of the Korean version of Disease Classification by three panels of 10 medical doctors each. Then, overall distribution, correlation coefficients, difference by each disease, and mean of differences by disease group were analyzed for comparison of disability weights between the Korean and Australian studies. RESULTS: Korean disability weights ranged from 0.037 to 0.927. While the rank correlation coefficient was moderate to high (rs=0.68), Korean disability weights were higher than the corresponding Australian ones in 79.7% of the 118 diseases. Of these, war, leprosy, and most injuries showed the biggest differences. On the contrary, many infectious and parasitic diseases comprised the greater part of diseases of which Korean disability weights were lower. The mean of the differences was the highest in injuries of GBD disease groups, and in cardiovascular disease, injuries, and malignant neoplasm of the Korean disease category. CONCLUSION: Korean disability weights were found to be valid on the basis of overall distribution pattern and correlation, and are expected to be used as basic data for broadening the scope of burden of disease study. However, some distinctive features still remain to be explored in following studies.; Summary

Comparative Study

Disability Weights for Diseases in Korea.: Jung Kyu Lee, Seok Jun Yoon, Young Kyung Do, Young Hoon Kwon, Chang Yup Kim, Kidong Park, Yong Ik Kim, Young Soo Shin; Korean J Prev Med. 2003;36(2):163-170.

14,951 View
45 Download

Abstract PDF: OBJECTIVES
This study aimed to develop an evaluation protocol of disability weights using person trade-off, and to test the reliability of the developed protocol in a Korean context. METHODS: To develop the valuation protocol, the Global Burden of Disease (GBD) and the Dutch studies were replicated and modified. Sixteen indicator conditions were selected from the Korean version of disease classification, which was based on that of the GBD Study, and the person trade-off method referred to the Dutch method. RESULTS: The disability weights were valued in a two step panel study. The first step was a carefully designed group process by three panels, using person trade-off to establish the disability weights for sixteen selected indicator conditions. The second step consisted of interpolation of the remaining diseases, on a disability scale, by the individual members of three panels. The members of three panels were all medical doctors, with sufficient knowledge of the consequences of a broad variety of diseases. The internal consistency of the Korean disability weights was satisfactory. Considerable agreement existed within each panel and among the panels. CONCLUSIONS: It was feasible to use a modified evaluation protocol from those used in GBD and Dutch studies. This would provide a rational basis for an international comparative study of disability weights.; Summary

Original Article

Measuring the Burden of Major Cancers in Korea Using Healthy Life-Year (HeaLY).: Yong Jun Choi, Seok Jun Yoon, Chang Yup Kim, Youngsoo Shin; Korean J Prev Med. 2001;34(4):372-378.

2,313 View
37 Download

Abstract PDF: OBJECTIVES
This study introduced the healthy life-year(HeaLY), a composite indicator of disease burden, and used it to estimate the burden of major cancers in Korea. METHODS: We collected data from the national death certificate database, the national health insurance claims database and the abridged life table. This data was used to create a spreadsheet and estimate the burden of major cancers by sex in terms of HeaLYs. RESULTS: The burden of 10 major cancers for males was 2,248.97 person-year in terms of HeaLYs. Stomach cancer, liver cancer, and lung cancer were responsible for 75.2% of the burden of 10 major cancers The disease burden of 10 major cancers for females was estimated to be 1,567.58 person-years. About two thirds of HeaLYs lost were from stomach cancer, liver cancer, lung cancer, colorectal cancer, and breast cancer. The rankings among 10 major cancers were somewhat different in terms of both HeaLYs and deaths as the HeaLY method considers both mortality and morbidity. CONCLUSIONS: Despite the limitations of the data sources, we conclude that HeaLY can aid in setting policy priorities concerning major cancers by estimating the disease burden of these cancers. Time-series analysis of the disease burden using HeaLY and DALY will elucidate the strengths and weaknesses of both methods.; Summary

English Abstract

The Socioeconomic Cost of Diseases in Korea.: Young Ho Jung, Sukja Ko; J Prev Med Public Health. 2006;39(6):499-504.

2,941 View
44 Download

Abstract PDF: OBJECTIVES
The aim of the study was to estimate the annual socioeconomic cost of diseases in Korea. METHODS: We estimate both the direct and indirect costs of diseases in Korea during 2003 using a prevalence-based approach. The direct cost estimates included medical expenditures, traffic costs and caregiver's cost, and the indirect costs, representing the loss of production, included lost workdays due to illness and lost earnings due to premature death, which were estimated based on the human capital theory. The cost estimates were reported at three different discount rates (0, 3 and 5%). RESULTS: The cost of diseases in Korea during 2003 was 38.4 trillion won based on 0% discount rate. This estimate represents approximately 5.3% of GDP. The direct and indirect costs were estimated to be 22.5 trillion (58.5% of total cost) and 15.9 trillion won (41.5%), respectively. It was also found that the cost for those aged 40~49 accounted for the largest proportion (21.7%) in relation to age groups. The cost of diseases for males was 23.5% higher than that for females. For major diseases, the total socioeconomic costs were 16.0, 13.4, 11.3 and 11.19% for neoplasms, and diseases of the digestive, respiratory and circulatory systems, respectively. CONCLUSIONS: This study can be expected to provide valuable information for determining intervention and funding priorities, and for planning health policies.; Summary

First
Prev
Page of 1
Next
Last

Search